Our #EYPT team is headed to Carlsbad, CA for the Women in Ophthalmology 2024 Summer Symposium! We look forward to a great few days of networking, learning and collaborating with trailblazers who are paving the way in the #Ophthalmology field.
EyePoint Pharmaceuticals
Biotechnology Research
Watertown, MA 12,307 followers
Delivering Innovation to the Eye™ NOW HIRING!
About us
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert’s proven intravitreal drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
- Website
-
http://www.eyepointpharma.com
External link for EyePoint Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Watertown, MA
- Type
- Public Company
- Specialties
- Ophthalmology, Glaucoma, WetAMD, Optometry, Eye Disease, and Retinal Disease
Locations
-
480 Pleasant St., Suite B300
Watertown, MA 02472, US
Employees at EyePoint Pharmaceuticals
Updates
-
“The most important asset that any organization has is its people.” – Jay Duker, #EYPT President and CEO Hear more from Jay in his interview with OWL: Advancing Diversity in Leadership here: https://lnkd.in/eKDGhKJN
-
-
#NOWHIRING | Medical Director, Clinical Development – Ophthalmology #EYPT is now hiring for a fully #Remote #MedicalDirector with a medical degree (MD - specialization in ophthalmology or Dr. of Optometry) and 2-4 years of experience in a clinical trial environment to be the primary sponsor medical person of contact for our clinical trials. Join a passionate team, committed to preventing blindness through innovative therapies today: https://lnkd.in/exnESHEQ #Careers #DEI #Inclusion #Diversity #ClinicalResearch Sherry Jenkins McHale, Theresa DiBiase, Monica Roy
-
-
#EYPT is committed to developing therapeutics to improve the lives of patients with serious retinal diseases. Our pipeline leverages proprietary technology for sustained intraocular drug delivery. Learn more about our #Pipeline & #Technology here: https://lnkd.in/dGEF4u5M
-
-
Please join us in congratulating our 2024 #Intern class! Each of these talented students worked hard during this program to grow their skills and provided invaluable work across our team. We celebrated their last day with well-deserved certificates from our President & CEO, Jay Duker. We see a bright future for each of you – congratulations!
-
-
-
-
-
+6
-
-
#EYPT is committed to developing solutions for patients facing serious #Retinal diseases, through our dedication to #Innovation, #Science and #Technology. Find out more here: https://lnkd.in/dGEF4u5M
-
Back to school time! In partnership with Life Science Cares Boston, EyePoint employees assembled backpacks full of necessities – binders, notebooks, highlighters, pencils, pens, folders and much more – to be delivered to Youth, Purpose & Partnership (YPP) students at Children's Services of Roxbury, Inc. (CSR) CSR brings peace of mind to Massachusetts’ most vulnerable families, providing housing for homeless families, affordable childcare, children’s mental health services, intensive foster care, and youth development programs. We were honored to be able to contribute to their important mission and deliver 48 backpacks for YPP students. Thank you to all who participated!
-
-
We are proud to have sponsored the 25th Annual Advanced Vitreoretinal Techniques & Technology Symposium and Fellows' Course – an opportunity for ophthalmologists to connect and share the latest on the diagnosis and management of vitreoretinal diseases. Special thanks to Zachariah Ballinger, Sr. Director for representing EyePoint Pharmaceuticals and learning about best practices ranging from risk management to involvement in clinical trials. We’re proud to drive growth and educational opportunities for future ophthalmologists to learn the latest #retina developments and innovations.
-
-
Thank you to the American Retina Forum for hosting another collaborative and informational event with the #Retina community! We’re heading back from #TheGoldenState excited to continue our mission to help provide innovative solutions for patients facing serious #RetinalDiseases.
-
-
Our #RetinalDisease-focused pipeline is designed to provide solutions for patients. When it comes to matters of sight, innovation is our vision. Learn more here: https://lnkd.in/eN4BpBGi
-